Use of in vitro lipid digestion data to explain the in vivo performance of triglyceride-based oral lipid formulations of poorly water-soluble drugs: studies with halofantrine

Christopher John H Porter; Ann Marie Kaukonen; Agnes Taillardat-Bertschinger; Benjamin James Boyd; Jacquelyn Michelle O'Connor; Glenn A Edwards; William Neil Charman

doi:10.1002/jps.20039

Use of in vitro lipid digestion data to explain the in vivo performance of triglyceride-based oral lipid formulations of poorly water-soluble drugs: studies with halofantrine

Christopher John H Porter, Ann Marie Kaukonen, Agnes Taillardat-Bertschinger, Benjamin James Boyd, Jacquelyn Michelle O'Connor, Glenn A Edwards, William Neil Charman

Drug Delivery Disposition & Dynamics

Research output: Contribution to journal › Article › Research › peer-review

171 Citations (Scopus)

Original language	English
Pages (from-to)	1110 - 1121
Number of pages	12
Journal	Journal of Pharmaceutical Sciences
Volume	93
Issue number	5
DOIs	https://doi.org/10.1002/jps.20039
Publication status	Published - 2004

Access to Document

10.1002/jps.20039

Cite this

Porter, C. J. H., Kaukonen, A. M., Taillardat-Bertschinger, A., Boyd, B. J., O'Connor, J. M., Edwards, G. A., & Charman, W. N. (2004). Use of in vitro lipid digestion data to explain the in vivo performance of triglyceride-based oral lipid formulations of poorly water-soluble drugs: studies with halofantrine. Journal of Pharmaceutical Sciences, 93(5), 1110 - 1121. https://doi.org/10.1002/jps.20039

Porter, Christopher John H ; Kaukonen, Ann Marie ; Taillardat-Bertschinger, Agnes ; Boyd, Benjamin James ; O'Connor, Jacquelyn Michelle ; Edwards, Glenn A ; Charman, William Neil. / Use of in vitro lipid digestion data to explain the in vivo performance of triglyceride-based oral lipid formulations of poorly water-soluble drugs: studies with halofantrine. In: Journal of Pharmaceutical Sciences. 2004 ; Vol. 93, No. 5. pp. 1110 - 1121.

@article{0470067baac44a99ad59910b07c849c7,

title = "Use of in vitro lipid digestion data to explain the in vivo performance of triglyceride-based oral lipid formulations of poorly water-soluble drugs: studies with halofantrine",

author = "Porter, {Christopher John H} and Kaukonen, {Ann Marie} and Agnes Taillardat-Bertschinger and Boyd, {Benjamin James} and O'Connor, {Jacquelyn Michelle} and Edwards, {Glenn A} and Charman, {William Neil}",

year = "2004",

doi = "10.1002/jps.20039",

language = "English",

volume = "93",

pages = "1110 -- 1121",

journal = "Journal of Pharmaceutical Sciences",

issn = "0022-3549",

publisher = "Elsevier",

number = "5",

}

Porter, CJH, Kaukonen, AM, Taillardat-Bertschinger, A, Boyd, BJ, O'Connor, JM, Edwards, GA & Charman, WN 2004, 'Use of in vitro lipid digestion data to explain the in vivo performance of triglyceride-based oral lipid formulations of poorly water-soluble drugs: studies with halofantrine', Journal of Pharmaceutical Sciences, vol. 93, no. 5, pp. 1110 - 1121. https://doi.org/10.1002/jps.20039

Use of in vitro lipid digestion data to explain the in vivo performance of triglyceride-based oral lipid formulations of poorly water-soluble drugs: studies with halofantrine. / Porter, Christopher John H; Kaukonen, Ann Marie; Taillardat-Bertschinger, Agnes; Boyd, Benjamin James; O'Connor, Jacquelyn Michelle; Edwards, Glenn A; Charman, William Neil.

In: Journal of Pharmaceutical Sciences, Vol. 93, No. 5, 2004, p. 1110 - 1121.

Research output: Contribution to journal › Article › Research › peer-review

TY - JOUR

T1 - Use of in vitro lipid digestion data to explain the in vivo performance of triglyceride-based oral lipid formulations of poorly water-soluble drugs: studies with halofantrine

AU - Porter, Christopher John H

AU - Kaukonen, Ann Marie

AU - Taillardat-Bertschinger, Agnes

AU - Boyd, Benjamin James

AU - O'Connor, Jacquelyn Michelle

AU - Edwards, Glenn A

AU - Charman, William Neil

PY - 2004

Y1 - 2004

U2 - 10.1002/jps.20039

DO - 10.1002/jps.20039

M3 - Article

VL - 93

SP - 1110

EP - 1121

JO - Journal of Pharmaceutical Sciences

JF - Journal of Pharmaceutical Sciences

SN - 0022-3549

IS - 5

ER -